Tuesday, January 10, 2017 9:34:57 AM
Keryx MC is at 673M vs 372M for SPPI. They expect revenue in Q4 at 9.5M vs 5.8 last year whereas I see SPPI revenue at potentially over 35M in Q4 (Yahoo analyst figures be damned at 30.3M). They have cash at 112M vs 172M for SPPI at end of Q3. Regarding the future, I’m too lazy/lack of time to check into Keryx now but I will pay attention to them at their quarterly but SPPI does have growing revenue potential in Evomela, incremental increases of their other drugs and has pivotal P3 studies for Rolontis and a P2 study for Poziotinib. SPPI seems undervalued to me.
To be continued after the next quarterly meetings…
Recent SPPI News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/09/2023 10:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:27 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 09:23:08 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM